Pro Share Advisors LLC Adaptive Biotechnologies Corp Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 30,600 shares of ADPT stock, worth $173,808. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,600
Previous 24,312 25.86%
Holding current value
$173,808
Previous $88,000 77.27%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$3.37 - $5.12 $21,190 - $32,194
6,288 Added 25.86%
30,600 $156,000
Q2 2024

Aug 13, 2024
SELL
$2.34 - $3.96 $14,660 - $24,809
-6,265 Reduced 20.49%
24,312 $88,000
Q1 2024

May 08, 2024
BUY
$2.88 - $4.8 $7,272 - $12,120
2,525 Added 9.0%
30,577 $98,000
Q4 2023

Feb 14, 2024
BUY
$3.46 - $5.33 $13,279 - $20,456
3,838 Added 15.85%
28,052 $137,000
Q3 2023

Nov 13, 2023
BUY
$5.07 - $8.44 $522 - $869
103 Added 0.43%
24,214 $131,000
Q2 2023

Aug 10, 2023
BUY
$6.19 - $8.78 $6,561 - $9,306
1,060 Added 4.6%
24,111 $161,000
Q1 2023

May 11, 2023
SELL
$7.8 - $10.11 $24,359 - $31,573
-3,123 Reduced 11.93%
23,051 $203,000
Q4 2022

Feb 02, 2023
BUY
$6.26 - $9.34 $11,668 - $17,409
1,864 Added 7.67%
26,174 $199,000
Q3 2022

Nov 04, 2022
BUY
$6.5 - $12.67 $4,608 - $8,983
709 Added 3.0%
24,310 $173,000
Q2 2022

Aug 01, 2022
BUY
$6.4 - $14.73 $57,382 - $132,069
8,966 Added 61.26%
23,601 $192,000
Q1 2022

May 10, 2022
SELL
$10.12 - $28.9 $53,018 - $151,407
-5,239 Reduced 26.36%
14,635 $203,000
Q4 2021

Feb 08, 2022
SELL
$25.17 - $36.85 $256,633 - $375,722
-10,196 Reduced 33.91%
19,874 $558,000
Q3 2021

Nov 12, 2021
BUY
$30.02 - $39.87 $145,867 - $193,728
4,859 Added 19.27%
30,070 $1.02 Million
Q2 2021

Aug 13, 2021
BUY
$32.22 - $44.59 $191,870 - $265,533
5,955 Added 30.93%
25,211 $1.03 Million
Q1 2021

May 14, 2021
SELL
$37.26 - $67.74 $68,968 - $125,386
-1,851 Reduced 8.77%
19,256 $775,000
Q4 2020

Feb 09, 2021
SELL
$45.01 - $65.47 $34,927 - $50,804
-776 Reduced 3.55%
21,107 $1.25 Million
Q3 2020

Nov 13, 2020
BUY
$35.79 - $48.81 $57,586 - $78,535
1,609 Added 7.94%
21,883 $1.06 Million
Q2 2020

Aug 03, 2020
BUY
$24.95 - $48.38 $78,268 - $151,768
3,137 Added 18.31%
20,274 $981,000
Q1 2020

May 15, 2020
SELL
$16.96 - $34.16 $165,376 - $333,094
-9,751 Reduced 36.27%
17,137 $476,000
Q4 2019

Feb 12, 2020
BUY
$24.56 - $32.8 $660,369 - $881,926
26,888 New
26,888 $804,000

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $812M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email